메뉴 건너뛰기




Volumn 119, Issue 1, 2002, Pages 15-24

STI-571 in chronic myelogenous leukaemia

Author keywords

BCR ABL; Clinical trials; CML; Imatinib mesylate; Resistance

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA INTERFERON; BCR ABL PROTEIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; HOMOHARRINGTONINE; HYDROXYUREA; IMATINIB; LEPTOMYCIN B; OROSOMUCOID; TROXACITABINE; VERAPAMIL;

EID: 0036400327     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03899.x     Document Type: Article
Times cited : (32)

References (72)
  • 1
    • 0029041749 scopus 로고
    • UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response
    • The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia
    • Allan, N.C., Richards, S.M. & Shepherd, P.C. (1995) UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia. Lancet, 345, 1392-1397.
    • (1995) Lancet , vol.345 , pp. 1392-1397
    • Allan, N.C.1    Richards, S.M.2    Shepherd, P.C.3
  • 2
    • 0011029442 scopus 로고    scopus 로고
    • Non-transplant treatment options for patients with newly diagnosed chronic myelogenous leukemia
    • www document
    • Baccarani, M. (2001) American Society of Hematology Education Program Book. Non-Transplant Treatment Options for Patients with Newly Diagnosed Chronic Myelogenous Leukemia. American Society of Hematology Education Program Book, 1, 87-112. (www document) URL. http://www.asheducationbook.org.
    • (2001) American Society of Hematology Education Program Book , vol.1 , pp. 87-112
    • Baccarani, M.1
  • 4
    • 0035929652 scopus 로고    scopus 로고
    • Roots of clinical resistance to STI-571 cancer therapy
    • Barthe, C., Cony-Makhoul, P., Melo, J.V. & Mahon, J.R. (2001) Roots of clinical resistance to STI-571 cancer therapy. Science, 293, 2163.
    • (2001) Science , vol.293 , pp. 2163
    • Barthe, C.1    Cony-Makhoul, P.2    Melo, J.V.3    Mahon, J.R.4
  • 6
    • 0032080097 scopus 로고    scopus 로고
    • Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta 1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors
    • Bhatia, R. & Verfaillie, C.M. (1998) Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta 1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors. Blood, 91, 3414-3422.
    • (1998) Blood , vol.91 , pp. 3414-3422
    • Bhatia, R.1    Verfaillie, C.M.2
  • 8
    • 0037045583 scopus 로고    scopus 로고
    • BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: A prospective study
    • von Bubnoff, N., Schneller, F., Peschel, C. & Duyster, J. (2002) BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study. Lancet, 359, 487-491.
    • (2002) Lancet , vol.359 , pp. 487-491
    • Von Bubnoff, N.1    Schneller, F.2    Peschel, C.3    Duyster, J.4
  • 9
    • 0030715606 scopus 로고    scopus 로고
    • Interferon-α versus chemotherapy for chronic myeloid leukemia: A meta-analysis of seven randomized trials
    • Chronic Myeloid Leukemia Trialists' Collaborative Group (1997) Interferon-α versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials. Journal of the National Cancer Institute, 89, 1616-1620.
    • (1997) Journal of the National Cancer Institute , vol.89 , pp. 1616-1620
  • 10
    • 0022981185 scopus 로고
    • Breakpoints on chromosome 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML): Amplification of rearranged c-abl oncogenes in CML blast crises
    • Collins, S.J. (1986) Breakpoints on chromosome 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML): amplification of rearranged c-abl oncogenes in CML blast crises. Journal of Clinical Investigation, 78, 1392-1396.
    • (1986) Journal of Clinical Investigation , vol.78 , pp. 1392-1396
    • Collins, S.J.1
  • 11
    • 0023155043 scopus 로고
    • Chronic myelogenous leukemia: Amplification of a rearranged c-abl oncogene in both chronic phase and blast crises
    • Collins, S.J. & Groudine, M.T. (1987) Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crises. Blood, 69, 893-898.
    • (1987) Blood , vol.69 , pp. 893-898
    • Collins, S.J.1    Groudine, M.T.2
  • 13
    • 0002199696 scopus 로고    scopus 로고
    • Multiple resistance mechanisms identified through studies of cell lines derived from chronic myelogenous leukemia patients progressing on STI-571 therapy
    • WWW document
    • Donato, N., Wu, J., Albitar, M., Arlinghaus, R., Kantarjian, H. & Talpaz, M. (2001a) Multiple resistance mechanisms identified through studies of cell lines derived from chronic myelogenous leukemia patients progressing on STI-571 therapy. ASH, 3206 (Abstract). (WWW document). URL. http://www.(Abstract)s-on-line.com/(Abstract)s/HEM/search/results.asp?Num= 0%2E8109354.
    • (2001) ASH , pp. 3206
    • Donato, N.1    Wu, J.2    Albitar, M.3    Arlinghaus, R.4    Kantarjian, H.5    Talpaz, M.6
  • 14
    • 0001958088 scopus 로고    scopus 로고
    • A dominant role for LYN kinase in K562 cells selected for resistance to STI-571
    • WWW document
    • Donato, N., Wu, J., Gallick, G., Arlinghaus, R. & Talpaz, M. (2001b) A dominant role for LYN Kinase in K562 cells selected for resistance to STI-571. ASH, 3487 (Abstract). (WWW document). URL. http://www.(Abstract)s-on-line.com/(Abstract)s/HEM/search/results.asp?Num= 0%2E1363139.
    • (2001) ASH , pp. 3487
    • Donato, N.1    Wu, J.2    Gallick, G.3    Arlinghaus, R.4    Talpaz, M.5
  • 15
    • 0011043229 scopus 로고    scopus 로고
    • Novel STI-571 resistance mechanisms in Ph (+) leukemia revealed through analysis of cells derived from STI-571 resistant chronic myelogenous leukemia (CML) patients
    • WWW document
    • Donato, N., Wu, J., Lin, H., Arlinghaus, R., Albitar, M., Patek, S. & Talpaz, M. (2002) Novel STI-571 resistance mechanisms in Ph (+) leukemia revealed through analysis of cells derived from STI-571 resistant chronic myelogenous leukemia (CML) patients. AACR (WWW document). URL. http://aacr02.agora.com/planner/displayabstract.asp?presentationid=3104.
    • (2002) AACR
    • Donato, N.1    Wu, J.2    Lin, H.3    Arlinghaus, R.4    Albitar, M.5    Patek, S.6    Talpaz, M.7
  • 16
    • 0025868121 scopus 로고
    • Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells
    • Dowding, C., Guo, A.P., Osterholz, J., Siczkowski, M., Goldman, J. & Gordon, M. (1991) Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood, 78, 499-505.
    • (1991) Blood , vol.78 , pp. 499-505
    • Dowding, C.1    Guo, A.P.2    Osterholz, J.3    Siczkowski, M.4    Goldman, J.5    Gordon, M.6
  • 17
    • 0002694995 scopus 로고    scopus 로고
    • STI-571 (Gleevac/Glivec, imatinib) versus interferon (IFN) + cytarabine as initial therapy for patients with CML: Results of a randomized study
    • Abstract (WWW document)
    • Druker, B.J. & International Randomized IFN vs. STI571 Study Group (IRIS) (2002) STI-571 (Gleevac/Glivec, imatinib) versus interferon (IFN) + cytarabine as initial therapy for patients with CML: results of a randomized study. ASCO, 1 Abstract (WWW document) URL. http://www.asco.org/asco/ascoMainConstructor/1,47468,_12|002324|00-29|00A| 00-18|002002|00-19|001,00.asp.
    • (2002) ASCO , pp. 1
    • Druker, B.J.1
  • 21
    • 0035810142 scopus 로고    scopus 로고
    • Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crises of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
    • Druker, B.J., Sawyers, C.L., Kantarjian, H., Resta, D., Reese, S., Ford, J., Capdeville, R. & Talpaz, M. (2001c) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crises of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. New England Journal of Medicine, 344, 1038-1042.
    • (2001) New England Journal of Medicine , vol.344 , pp. 1038-1042
    • Druker, B.J.1    Sawyers, C.L.2    Kantarjian, H.3    Resta, D.4    Reese, S.5    Ford, J.6    Capdeville, R.7    Talpaz, M.8
  • 24
    • 0034665780 scopus 로고    scopus 로고
    • Bcr/Abl activates transcription of Bcl-X gene through STAT 5
    • Gesbert, F. & Griffin, J.D. (2000) Bcr/Abl activates transcription of Bcl-X gene through STAT 5. Blood, 96, 2269-2276.
    • (2000) Blood , vol.96 , pp. 2269-2276
    • Gesbert, F.1    Griffin, J.D.2
  • 25
    • 0034671745 scopus 로고    scopus 로고
    • BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-kinase/AKT pathway
    • Gesbert, F., Sellers, W.R., Signoretti, S., Loda, M. & Griffin, J.D. (2000) BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway. Journal of Biological Chemistry, 275, 39223-39230.
    • (2000) Journal of Biological Chemistry , vol.275 , pp. 39223-39230
    • Gesbert, F.1    Sellers, W.R.2    Signoretti, S.3    Loda, M.4    Griffin, J.D.5
  • 27
    • 0023270373 scopus 로고
    • Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia
    • Gordon, M.Y., Dowding, C.R., Riley, G.P., Goldman, J.M. & Greaves, M.F. (1987) Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature, 328, 342-344.
    • (1987) Nature , vol.328 , pp. 342-344
    • Gordon, M.Y.1    Dowding, C.R.2    Riley, G.P.3    Goldman, J.M.4    Greaves, M.F.5
  • 28
    • 0035800507 scopus 로고    scopus 로고
    • Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
    • Gorre, M.E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P.N. & Sawyers, C.L. (2001) Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science, 293, 876-880.
    • (2001) Science , vol.293 , pp. 876-880
    • Gorre, M.E.1    Mohammed, M.2    Ellwood, K.3    Hsu, N.4    Paquette, R.5    Rao, P.N.6    Sawyers, C.L.7
  • 29
    • 0035207448 scopus 로고    scopus 로고
    • The biology of signal transduction inhibition: Basic science to novel therapies
    • Griffin, J. (2001) The biology of signal transduction inhibition: basic science to novel therapies. Seminars in Oncology, 28, 3-8.
    • (2001) Seminars in Oncology , vol.28 , pp. 3-8
    • Griffin, J.1
  • 30
    • 0037045574 scopus 로고    scopus 로고
    • Resistance to targeted therapy in leukaemia
    • Griffin, J. (2002) Resistance to targeted therapy in leukaemia. Lancet, 359, 458-459.
    • (2002) Lancet , vol.359 , pp. 458-459
    • Griffin, J.1
  • 31
    • 0021346853 scopus 로고
    • Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
    • Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R. & Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell, 36, 93-99.
    • (1984) Cell , vol.36 , pp. 93-99
    • Groffen, J.1    Stephenson, J.R.2    Heisterkamp, N.3    De Klein, A.4    Bartram, C.R.5    Grosveld, G.6
  • 33
    • 0034703711 scopus 로고    scopus 로고
    • Adaptive amplification: An inducible chromosomal instability mechanism
    • Hastings, P.J., Bull, H.J., Klump, J.R. & Rosenberg, S.M. (2000) Adaptive amplification: an inducible chromosomal instability mechanism. Cell, 103, 723-731.
    • (2000) Cell , vol.103 , pp. 723-731
    • Hastings, P.J.1    Bull, H.J.2    Klump, J.R.3    Rosenberg, S.M.4
  • 34
    • 0027164941 scopus 로고
    • Randomized comparison of busulphan and hydroxyurea in chronic myelogenous leukemia: Prolongation of survival by hydroxyurea
    • The German CML Study Group
    • Hehlmann, R., Heimpel, H., Hasford, J., Kolb, H.J., Pralle, H., Hossfeld, D.K., Queisser, W., Loffler, H., Heinze, B. & Georgii, A. (1993) Randomized comparison of busulphan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group. Blood, 82, 398-407.
    • (1993) Blood , vol.82 , pp. 398-407
    • Hehlmann, R.1    Heimpel, H.2    Hasford, J.3    Kolb, H.J.4    Pralle, H.5    Hossfeld, D.K.6    Queisser, W.7    Loffler, H.8    Heinze, B.9    Georgii, A.10
  • 35
    • 0020972979 scopus 로고
    • Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia
    • Heisterkamp, N., Stephenson, J.R., Groffen, J., Hansen, P.F., de Klein, A., Bartram, C.R. & Grosveld, G. (1983) Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature, 306, 239-242.
    • (1983) Nature , vol.306 , pp. 239-242
    • Heisterkamp, N.1    Stephenson, J.R.2    Groffen, J.3    Hansen, P.F.4    De Klein, A.5    Bartram, C.R.6    Grosveld, G.7
  • 37
    • 0036493544 scopus 로고    scopus 로고
    • Ph+ acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation
    • Hofmann, W.K., Jones, L.C., Lemp, N.A., de Vos, S., Gschaidmeier, H., Hoelzer, D., Ottmann, O.G. & Koeffler, H.P. (2002a) Ph+ acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation. Blood, 99, 1860-1862.
    • (2002) Blood , vol.99 , pp. 1860-1862
    • Hofmann, W.K.1    Jones, L.C.2    Lemp, N.A.3    De Vos, S.4    Gschaidmeier, H.5    Hoelzer, D.6    Ottmann, O.G.7    Koeffler, H.P.8
  • 38
    • 0037045589 scopus 로고    scopus 로고
    • Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: A gene-expression study
    • Hofmann, W.K., de Vos, S., Elashoff, D., Gschaidmeier, H., Hoelzer, D., Koeffler, P. & Ottmann, O.G. (2002b) Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study. Lancet, 359, 481-486.
    • (2002) Lancet , vol.359 , pp. 481-486
    • Hofmann, W.K.1    De Vos, S.2    Elashoff, D.3    Gschaidmeier, H.4    Hoelzer, D.5    Koeffler, P.6    Ottmann, O.G.7
  • 39
    • 0029952614 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for CML: A report from the International Bone Marrow Transplant Registry
    • Horowitz, M.M., Rowlings, P.A. & Passweg, J.R. (1996) Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry. Bone Marrow Transplantation, 17, S5-S6.
    • (1996) Bone Marrow Transplantation , vol.17
    • Horowitz, M.M.1    Rowlings, P.A.2    Passweg, J.R.3
  • 40
    • 0345405480 scopus 로고    scopus 로고
    • α1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571
    • Jorgensen, H.G., Elliott, M.A., Allan, E.K., Carr, C.E., Holyoake, T.L. & Smith, K.D. (2002) α1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571. Blood, 99, 713-715.
    • (2002) Blood , vol.99 , pp. 713-715
    • Jorgensen, H.G.1    Elliott, M.A.2    Allan, E.K.3    Carr, C.E.4    Holyoake, T.L.5    Smith, K.D.6
  • 41
    • 0035934067 scopus 로고    scopus 로고
    • Chronic myelogenous leukemia
    • Kalidas, M., Kantarjian, H. & Talpaz, M. (2001) Chronic Myelogenous Leukemia. JAMA, 286, 895-898.
    • (2001) JAMA , vol.286 , pp. 895-898
    • Kalidas, M.1    Kantarjian, H.2    Talpaz, M.3
  • 42
    • 0035210658 scopus 로고    scopus 로고
    • Imatinib mesylate. Clinical results in Philadelphia chromosome-positive leukemias
    • Kantarjian, H.M. & Talpaz, M. (2001) Imatinib Mesylate. Clinical results in philadelphia chromosome-positive leukemias. Seminars in Oncology, 28, 9-18.
    • (2001) Seminars in Oncology , vol.28 , pp. 9-18
    • Kantarjian, H.M.1    Talpaz, M.2
  • 43
    • 0028813711 scopus 로고
    • Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy
    • Kantarjian, H.M., Smith, T.L., O'Brien, S., Beran, M., Pierce, S. & Talpaz, M. (1995) Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. Annals of Internal Medicine, 122, 254-261.
    • (1995) Annals of Internal Medicine , vol.122 , pp. 254-261
    • Kantarjian, H.M.1    Smith, T.L.2    O'Brien, S.3    Beran, M.4    Pierce, S.5    Talpaz, M.6
  • 45
    • 0003215157 scopus 로고    scopus 로고
    • High rates of early major and complete cytogenetic responses with imatinib mesylate therapy given at 400 mg or 800 mg orally daily in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
    • Abstract 1043. (WWW document)
    • Kantarjian, H.M., Jorge, C., O'Brien, S., Giles, F., Thomas, D., Faderl, S., Garcia-Manero, G., Rios, M., Letvak, L., Bochinski, K., Shan, J. & Talpaz, M. (2002b) High rates of early major and complete cytogenetic responses with imatinib mesylate therapy given at 400 mg or 800 mg orally daily in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. ASCO, Abstract 1043. (WWW document). URL. http://www.asco.org/asco/ascoMainConstructor/1,47468,_12|002324|00-29|00A| 00-18|002002|00-19|001043,00.asp.
    • (2002) ASCO
    • Kantarjian, H.M.1    Jorge, C.2    O'Brien, S.3    Giles, F.4    Thomas, D.5    Faderl, S.6    Garcia-Manero, G.7    Rios, M.8    Letvak, L.9    Bochinski, K.10    Shan, J.11    Talpaz, M.12
  • 48
    • 0023753576 scopus 로고
    • The molecular genetics of Philadelphia chromosome-positive leukemias
    • Kurzrock, R., Gutterman, J.U. & Talpaz, M. (1988) The molecular genetics of Philadelphia chromosome-positive leukemias. New England Journal of Medicine, 319, 990-998.
    • (1988) New England Journal of Medicine , vol.319 , pp. 990-998
    • Kurzrock, R.1    Gutterman, J.U.2    Talpaz, M.3
  • 49
    • 0026666779 scopus 로고
    • Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl
    • Laneuville, P., Sun, G., Timm, M. & Vekemans, M. (1992) Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl. Blood, 80, 1788-1797.
    • (1992) Blood , vol.80 , pp. 1788-1797
    • Laneuville, P.1    Sun, G.2    Timm, M.3    Vekemans, M.4
  • 50
    • 0034254368 scopus 로고    scopus 로고
    • Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance
    • Mahon, F.X., Deininger, M.W., Schultheis, B., Chabrol, J., Reiffers, J., Goldman, J.M. & Melo, J.V. (2000) Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance. Blood, 96, 1070-1079.
    • (2000) Blood , vol.96 , pp. 1070-1079
    • Mahon, F.X.1    Deininger, M.W.2    Schultheis, B.3    Chabrol, J.4    Reiffers, J.5    Goldman, J.M.6    Melo, J.V.7
  • 51
    • 0000286732 scopus 로고
    • A minute chromosome in human chronic granulocytic leukemia
    • Nowell, P.C. & Hungerford, D.A. (1960) A minute chromosome in human chronic granulocytic leukemia. Science, 132, 1497.
    • (1960) Science , vol.132 , pp. 1497
    • Nowell, P.C.1    Hungerford, D.A.2
  • 52
    • 0029154919 scopus 로고
    • A randomized trial comparing interferon-alpha with busulphan for newly diagnosed chronic myelogenous leukemia in chronic phase
    • Ohnishi, K., Ohno, R., Tomonaga, M., Kamada, N., Onozawa, K., Kuramoto, A., Dohy, H., Mizoguchi, H., Miyawaki, S. & Tsubaki, K. (1995) A randomized trial comparing interferon-alpha with busulphan for newly diagnosed chronic myelogenous leukemia in chronic phase. Blood, 86, 906-916.
    • (1995) Blood , vol.86 , pp. 906-916
    • Ohnishi, K.1    Ohno, R.2    Tomonaga, M.3    Kamada, N.4    Onozawa, K.5    Kuramoto, A.6    Dohy, H.7    Mizoguchi, H.8    Miyawaki, S.9    Tsubaki, K.10
  • 53
    • 0029845079 scopus 로고    scopus 로고
    • p210 BCR/ABL, p190 BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines
    • Okuda, K., Golub, T.R., Gilliland, D.G. & Griffin, J.D. (1996) p210 BCR/ABL, p190 BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Oncogene, 13, 1147-1152.
    • (1996) Oncogene , vol.13 , pp. 1147-1152
    • Okuda, K.1    Golub, T.R.2    Gilliland, D.G.3    Griffin, J.D.4
  • 54
    • 0027361154 scopus 로고
    • Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: Effect on remission duration and survival. Cancer and Leukemia Group B Study 8583
    • Ozer, H., George, S.L., Schiffer, C.A., Rao, K., Rao, P.N., Wurster-Hill, D.H., Arthur, D.D., Powell, B., Gottlieb, A. & Peterson, B.A. (1993) Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival. Cancer and Leukemia Group B Study 8583. Blood, 82, 2975-2984.
    • (1993) Blood , vol.82 , pp. 2975-2984
    • Ozer, H.1    George, S.L.2    Schiffer, C.A.3    Rao, K.4    Rao, P.N.5    Wurster-Hill, D.H.6    Arthur, D.D.7    Powell, B.8    Gottlieb, A.9    Peterson, B.A.10
  • 55
    • 0011047987 scopus 로고    scopus 로고
    • WP744, a novel anthracycline with enhanced apoptotic and anti-proliferative activity on STI-571 resistant leukemic cells: Design, synthesis, and evaluation
    • abstract 4197. (WWW document)
    • Priebe, W., Evrony, G., Fokt, I., Talpaz, M. & Donato, N. (2002) WP744, a novel anthracycline with enhanced apoptotic and anti-proliferative activity on STI-571 resistant leukemic cells: Design, synthesis, and evaluation. AACR abstract 4197. (WWW document) URL. http://aacr02.agora.com/planner/displayabstract.asp?presentationid=3106.
    • (2002) AACR
    • Priebe, W.1    Evrony, G.2    Fokt, I.3    Talpaz, M.4    Donato, N.5
  • 57
    • 0015694748 scopus 로고
    • A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
    • Rowley, J.D. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243, 290-293.
    • (1973) Nature , vol.243 , pp. 290-293
    • Rowley, J.D.1
  • 58
  • 59
    • 0033614446 scopus 로고    scopus 로고
    • Medical progress. Chronic myeloid leukemia
    • Sawyers, C.L. (1999) Medical Progress. Chronic Myeloid Leukemia. New England Journal of Medicine, 340, 1330-1340.
    • (1999) New England Journal of Medicine , vol.340 , pp. 1330-1340
    • Sawyers, C.L.1
  • 62
    • 0021802841 scopus 로고
    • Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
    • Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature, 315, 550-554.
    • (1985) Nature , vol.315 , pp. 550-554
    • Shtivelman, E.1    Lifshitz, B.2    Gale, R.P.3    Canaani, E.4
  • 63
    • 0020590588 scopus 로고
    • Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia
    • Talpaz, M., McCredie, K.B., Mavligit, G.M. & Gutterman, J.U. (1983) Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood, 62, 689-692.
    • (1983) Blood , vol.62 , pp. 689-692
    • Talpaz, M.1    McCredie, K.B.2    Mavligit, G.M.3    Gutterman, J.U.4
  • 64
    • 0022623818 scopus 로고
    • Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia
    • Talpaz, M., Kantarjian, H.M., McCredie, K., Trujillo, J.M., Keating, M.J. & Gutterman, J.U. (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. New England Journal of Medicine, 314, 1065-1069.
    • (1986) New England Journal of Medicine , vol.314 , pp. 1065-1069
    • Talpaz, M.1    Kantarjian, H.M.2    McCredie, K.3    Trujillo, J.M.4    Keating, M.J.5    Gutterman, J.U.6
  • 66
    • 23444462074 scopus 로고
    • Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia
    • The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New England Journal of Medicine, 330, 820-825.
    • (1994) New England Journal of Medicine , vol.330 , pp. 820-825
  • 67
    • 0035895106 scopus 로고    scopus 로고
    • Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells
    • Tipping, A.J., Mahon, F.X., Lagarde, V., Goldman, J.M. & Melo, J.V. (2001) Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells. Blood, 98, 3864-3867.
    • (2001) Blood , vol.98 , pp. 3864-3867
    • Tipping, A.J.1    Mahon, F.X.2    Lagarde, V.3    Goldman, J.M.4    Melo, J.V.5
  • 69
    • 0035122485 scopus 로고    scopus 로고
    • Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase
    • Vigneri, P. & Wang, J.Y. (2001) Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nature Medicine, 7, 228-234.
    • (2001) Nature Medicine , vol.7 , pp. 228-234
    • Vigneri, P.1    Wang, J.Y.2
  • 70
    • 0034210577 scopus 로고    scopus 로고
    • Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines
    • Weisberg, E. & Griffin, J.D. (2000) Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines. Blood, 95, 3498-3505.
    • (2000) Blood , vol.95 , pp. 3498-3505
    • Weisberg, E.1    Griffin, J.D.2
  • 71
    • 0010956417 scopus 로고    scopus 로고
    • Lyn kinase activation and overexpression in K562 cells selected for resistance to BCR-ABL kinase inhibitor (STI-571, Gleevec, imatinib mesylate)
    • abstract 2101. (WWW document)
    • Wu, J., Talpaz, M., Gallick, G., Lin, H., Arlinhaus, R. & Donato, N. (2002) Lyn kinase activation and overexpression in K562 cells selected for resistance to BCR-ABL kinase inhibitor (STI-571, Gleevec, imatinib mesylate). AACR, abstract 2101. (WWW document). URL. http://aacr02.agora.com/planner/displayabstract.asp?presentationid=6875.
    • (2002) AACR
    • Wu, J.1    Talpaz, M.2    Gallick, G.3    Lin, H.4    Arlinhaus, R.5    Donato, N.6
  • 72
    • 0029042707 scopus 로고
    • Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562
    • Wu, S.Q., Voelkerding, K.V., Sabatini, L., Chen, X.R., Huang, J. & Meisner, L.F. (1995) Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562. Leukemia, 9, 858-862.
    • (1995) Leukemia , vol.9 , pp. 858-862
    • Wu, S.Q.1    Voelkerding, K.V.2    Sabatini, L.3    Chen, X.R.4    Huang, J.5    Meisner, L.F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.